US FDA issues two new clinical trial design guidances
This article was originally published in Scrip
Executive Summary
The US FDA has issued two new draft guidance documents regarding clinical trial designs: Guidance for Industry: Adaptive Design Clinical Trials for Drugs and Biologics, and Guidance for Industry: Non-inferiority Clinical Trials.